Malignant mast cell neoplasm Completed Phase Trials for Valganciclovir (DB01610)

Also known as: Malignant Mast Cell Tumors / Mast Cell Leukemia (MCL) / Leukemia, Mast Cell / Mast Cell Leukemia / Malignant-mast cell tumours / Mast-Cell Sarcoma

IndicationStatusPhase
DBCOND0007107 (Malignant mast cell neoplasm)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01199562Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantSupportive Care